๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Identification and expansion of human lymphokine-activated killer cells: Implications for the immunotherapy of cancer

โœ Scribed by John M. Skibber; M.T. Lotze; I. Uppenkamp; W. Ross; S.A. Rosenberg

Book ID
116010074
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
742 KB
Volume
42
Category
Article
ISSN
0022-4804

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunotherapy of cancer with lymphokines
Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells
โœ John W. Yarbro ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 996 KB

Our expanding knowledge of the immune system has provided a basis of rationality for immunotherapy . Some non-specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cance

The requirements for successful immunoth
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells
โœ Reyer T. Ottow; Alexander M. M. Eggermont; E. Philip Steller; Paul H. Sugarbaker ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 907 KB

In a significant proportion of patients with gastrointestinal and ovarian malignancy the peritoneal cavity is a prominent site at which surgical treatment fails. Adjuvant treatments directed at this site should be investigated in an attempt to improve survival in patients with these cancers. In the